Numerous evidences indicate that TRIM24 upregulation is significantly associated with cancer development and poor prognosis in multiple cancer types such as bladder cancer (23), gastric cancer (24), non-small cell lung cancer (25), and breast cancer (26). This evidence concerns the gene TRIM24 and non-small cell lung carcinoma.